Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Akanda Corp. (AKAN : NSDQ)

• Company Description    Akanda Corp. provides medical cannabis and wellness platform. The company's initial portfolio includes Bophelo Bioscience & Wellness, a GACP qualified cultivation campus in the Kingdom of Lesotho in Southern Africa and CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK. Akanda Corp. is based in LONDON. Number of Employees: 2

• Price / Volume Information    Yesterday's Closing Price: $1.41 Daily Weekly Monthly 20 Day Moving Average: 65,988 shares Shares Outstanding: 1.43 (millions) Market Capitalization: $2.01 (millions) Beta: 1.60 52 Week High: $5.08 52 Week Low: $0.93 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 4.91% 0.98% 12 Week 28.18% 7.82% Year To Date -11.88% -17.47%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 100 KING ST. W SUITE 1600 - TORONTO,A6 ON M5X 1G5 CAN ph: 202-498-7917 fax: - None http://www.akandacorp.com

• General Corporate Information    Officers Katharyn Field - Interim Chief Executive Officer and Executive Dire Gurcharn Deol - Chief Financial Officer David Jenkins - Director Christopher Cooper - Director Usama Chaudhry - Director Peer Information Akanda Corp. (BJCT) Akanda Corp. (CADMQ) Akanda Corp. (APNO) Akanda Corp. (UPDC) Akanda Corp. (IMTIQ) Akanda Corp. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 00971M403 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 1.43 Most Recent Split Date: 11.00 (0.50:1) Beta: 1.60 Market Capitalization: $2.01 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.47 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 1.39 Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 1.39 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -390.44 Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - 3.00 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - 0.00

Powered by Zacks Investment Research ©